A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803
Clinical trial NCT01851512 · COMPLETED
Trial details
- NCT number
- NCT01851512
- Sponsor
- Dong-A Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2010-08-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.